Advanced Preclinical Evaluation Frameworks for Autologous iPSC Therapies

• Patient-Derived Complexity: Leveraging bespoke evaluation platforms to navigate the biological diversity of patient-specific iPSC sources
• Non-Editing Solutions: Establishing high-fidelity functional assays to ensure therapeutic consistency and IND readiness in non-gene edited products
• Translation Strategy: Data-driven approaches to bridge the gap between laboratory-scale characterization and clinical-grade therapeutic production

Speakers:

Seongho Bae

Head of Research & Development

Karis Bio